Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT02303821 · COMPLETED
Trial details
- NCT number
- NCT02303821
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-16
- Primary completion
- 2024-06-28
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.